1. Home
  2. PGR vs SNY Comparison

PGR vs SNY Comparison

Compare PGR & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGR
  • SNY
  • Stock Information
  • Founded
  • PGR 1937
  • SNY 1994
  • Country
  • PGR United States
  • SNY France
  • Employees
  • PGR N/A
  • SNY N/A
  • Industry
  • PGR Property-Casualty Insurers
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • PGR Finance
  • SNY Health Care
  • Exchange
  • PGR Nasdaq
  • SNY Nasdaq
  • Market Cap
  • PGR 147.7B
  • SNY 127.5B
  • IPO Year
  • PGR N/A
  • SNY N/A
  • Fundamental
  • Price
  • PGR $257.00
  • SNY $47.78
  • Analyst Decision
  • PGR Buy
  • SNY Buy
  • Analyst Count
  • PGR 17
  • SNY 2
  • Target Price
  • PGR $259.31
  • SNY $57.50
  • AVG Volume (30 Days)
  • PGR 2.1M
  • SNY 2.3M
  • Earning Date
  • PGR 10-15-2024
  • SNY 10-25-2024
  • Dividend Yield
  • PGR 0.16%
  • SNY 4.27%
  • EPS Growth
  • PGR 199.14
  • SNY N/A
  • EPS
  • PGR 13.76
  • SNY 4.00
  • Revenue
  • PGR $71,959,400,000.00
  • SNY $54,031,898,261.00
  • Revenue This Year
  • PGR N/A
  • SNY $3.18
  • Revenue Next Year
  • PGR $17.02
  • SNY $6.67
  • P/E Ratio
  • PGR $18.67
  • SNY $23.82
  • Revenue Growth
  • PGR 22.67
  • SNY 6.01
  • 52 Week Low
  • PGR $149.14
  • SNY $45.22
  • 52 Week High
  • PGR $263.85
  • SNY $58.97
  • Technical
  • Relative Strength Index (RSI)
  • PGR 55.74
  • SNY 25.09
  • Support Level
  • PGR $252.74
  • SNY $47.46
  • Resistance Level
  • PGR $263.65
  • SNY $48.67
  • Average True Range (ATR)
  • PGR 5.42
  • SNY 0.72
  • MACD
  • PGR 0.32
  • SNY -0.31
  • Stochastic Oscillator
  • PGR 71.87
  • SNY 5.07

About PGR Progressive Corporation (The)

Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 20 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Share on Social Networks: